INTRODUCTION
Hereditary leukonychia (HL) or 'porcelain nails' is a rare genetic nail disorder in which the hands and feet present with a whitening of the nail plate of all 20 nails. HL can comanifest with cutaneous or systemic pathologies such as keratosis palmoplantaris, severe keratosis pilaris, pili torti, hypotrichosis, koilonychias, renal calculi and hair dysplasia; but also occurs as an isolated feature [1] . While dominant and recessive inheritance has been reported, the pathophysiology and genetic basis of HL remains unclear. Previous genetic analyses have associated HL with mutations in the chromosomal region 3p21.3-p22, and the gene encoding phospholipase C (PLC) delta-1 (PLC 1) [1] [2] [3] .
PLC 1 belongs to the ubiquitous family of PLC enzymes, key components of signal transduction in a wide range of cellular signalling pathways. PLCs hydrolyse the membrane lipid substrate, phosphatidylinositol 4,5-bisphosphate (PIP 2 ) to generate two second messengers, inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG). DAG mediates the activation of protein kinase C (PKC), while IP 3 binds to the IP 3 receptors (IP 3 Rs) in the endoplasmic reticulum (ER) membrane which opens the intrinsic cation channel to release calcium ions from intracellular stores [4, 5] . Currently, there are 13 mammalian PLC isozymes, grouped into six classes according to structure and activation mechanism: PLCbeta (PLCβ1-4), PLC-gamma (PLCγ1-2), PLC-delta (PLCδ1, 3, and 4), PLC-epsilon (PLCε), PLC-zeta (PLCζ) and PLC-eta (PLCη1-2) [4, 5] . The -type PLCs, δ1, δ3, and δ4, are primarily expressed in mammals. Among these, PLC 1 is expressed abundantly in most tissues.
PLC 1 is a multi-domain enzyme, whose 3D-structure has been determined [6] to comprise an N-terminal pleckstrin homology (PH) domain followed by two pairs of EF hand
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This article is protected by copyright. All rights reserved. motifs, the X and Y catalytic domains and a C-terminal C2 domain ( Figure 1A ). Each domain confers a specific role on the hydrolytic enzyme function of PLC 1. The PH domain binds both PIP 2 and IP 3 , and the PH domain-PIP 2 interaction anchors PLC 1 to phospholipid membranes, increasing PIP 2 hydrolysis rates [7] . The EF hand domains consist of four helixloop-helix motifs divided in two pair-wise lobes. Although these domains possess Ca 2+ -binding residues, also identified in various other Ca 2+ binding proteins such as calmodulin, the requirement for Ca 2+ binding to the EF hands is not essential for PLCδ1 function [8] .
The first lobe of the PLC 1 EF hands is involved in Ca 2+ -independent binding of PLCδ1 to anionic phospholipids [9] , while the second lobe is vital for enzymatic activity and structural stability [8] . The PLC 1 catalytic domain has a unique split triose isomerase (TIM) barrel structure, of which the two halves are termed X and Y. The X and Y regions are joined by the flexible, unstructured, auto-inhibitory XY linker [10], which contains a Ca 2+ binding site that confers Ca 2+ -dependent enzymatic activity of PLC 1 [6] . The C-terminal C2 domain is involved in Ca 2+ -dependent membrane binding of PLC 1, interacting with phosphatidylserine to form a C2-Ca 2+ -phosphatidylserine ternary complex that enhances PLCδ1 enzymatic activity [11] .
Immunohistochemical analyses have demonstrated high PLC 1concentrations within the human nail matrix, suggesting a potential role for PLC 1 in nail development [1] .
Significantly, genome wide analyses of individuals with HL have identified a spectrum of mutations in the PLC 1 gene [1] [2] [3] . However, the mechanism by which these mutations alter the molecular properties of PLC 1 to cause the leukonychia phenotype is currently unknown.
In the present study, we introduce three HL-associated human PLCδ1 mutations (C209R, A574T and S740R) into the rat PLCδ1 (C188R, A553T and S719R; Figure 1A ) and evaluate
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the impact of these mutations on the biophysical and biochemical properties of PLCδ1.
Moreover, we also characterize a PLCδ1 mutation identified in a Pakistani family (S740RfsX19) [3] by incorporating a stop codon 19 amino acids adjacent to the S719R point mutation in rat PLCδ1 and determine how truncation of the C-terminal 18 residues alters PLCδ1function.
RESULTS

PLCδ1 construct expression
To investigate how the C188R, A553T and S719R mutations affects the biophysical and biochemical properties of wild-type PLC 
Biophysical characterisation of PLCδ1 wild type and mutant proteins
Circular dichroism (CD) spectra of wild-type and mutant PLC 1 protein exhibited high congruence. The extrema at 190 and 208 nm, and shoulder at ~221 nm are indicative of substantial α-helical content ( Fig. 2A, B) . Spectra recorded in the absence ( Fig. 2A) 
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content observed in the combined X-ray structures of the N-and C-terminal regions of rat PLC 1 (pdb codes 1DJG and 1MAI; [13, 14] ), indicating expressed proteins appear to adopt the correct conformation.
To evaluate thermal stability of the purified wild-type and mutant PLC 1 proteins, the CD signal was monitored at 221 nm at increasing temperatures (Figs. 2C, D , which remained unaffected (Fig. 2D, E) . emission maximum at 325 nm, while at 5M GdmCl the unfolded molecules possessed an emission maximum at ∼345 nm. This red-shift could render intensity measurements at a fixed wavelength misleading. Therefore, to avoid such issues, the intensity-weighted average emission wavelength was calculated from the collected spectra at each denaturant concentration [15] . Typical intensity-weighted average wavelength vs. GdmCl concentration plots for both the PLC 1 Ca 2+ -free and Ca 2+ -rich samples are presented in Figure 3A . In contrast to the thermal denaturation (Fig. 2) , the reversibility of the chemical denaturation
profile allows for the extraction of meaningful thermodynamic parameters, using a three-state equilibrium model to analyse the data [16] .
The results of the non-linear least squares fits are shown in Figure 3 
Binding of PLCδ1 mutants to PIP 2
To examine the effect of mutations on the binding properties of PLCδ1 to PIP 2 (Fig. 4 ).
These data suggest that none of these mutations alter PLCδ1 binding to PIP 2 .
Enzymatic characterization of C188R, A553T and S719R mutants
The specific PIP 2 hydrolytic activity of each recombinant protein was determined using an in vitro [ 3 H]PIP 2 hydrolysis assay [19] [20] [21] . The enzyme-specific activities are summarized in Figure 5A and Table 1 revealing that the wild-type and S719R exhibited no difference in enzymatic activities. C188R retained ∼85% of WT enzymatic activity. In contrast, A553T showed a ∼40% increase in its enzymatic activity compared to wild-type PLCδ1 (Table 1) 
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This article is protected by copyright. All rights reserved. Figure 5C shows NusA-PLCδ1 WT and NusA-PLCδ1 S719 fsX19 fusion proteins analysed by SDS-PAGE and immunoblot detection. The major protein band displayed a mobility corresponding to the predicted molecular mass for each construct and these bands were also confirmed by the anti-PLCδ1 antibody. PIP 2 hydrolytic enzyme activity was determined using the standard [ 3 H]PIP 2 hydrolysis assay. The histogram of Figure 5D summarizes the enzyme-specific activity values obtained for each protein, revealing that does not appear to exert a major effect on PLCδ1 activity, an 18 amino acid truncation from the PLCδ1 C-terminus has a significantly deleterious impact on enzymatic function.
DISCUSSION
Hereditary leuconychia is a rare nail pathology in which patients present with a partial or totally white nail plate. Recent studies provided the first genetic links between PLC 1 and HL by identifying mutations in the PLC 1 protein sequence of family members exhibiting characteristic features of HL [1] [2] [3] . Both dominant and recessive inheritance is known to underlie manifestation of this nail disorder. Despite the in-depth structural characterization of PLC 1, the specific physiological role of this enzyme has only recently become more evident through the identification of its contribution to human disease.
PLC 1 was significantly down-regulated in colorectal- [23] , breast- [24] , and gastric- [25] cancers, including chronic myeloid leukaemia [26] . More specifically, the PLC 1 promoter in 79% of analysed colorectal cancer cell lines was methylated, suggesting the potential involvement of PLC 1 in tumour suppression [23] . Furthermore, PLC 1 cellular distribution alters in a cell cycle-dependant manner, while suppression of PLC 1 leads to
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increased levels of cyclin E [27] , indicating that PLC 1 may contribute to cell cycle regulation. Studies with transgenic mice suggest a role for PLC 1 in thermogenesis and adipogenesis, as PLC 1 -/-mice had significantly lower body-weight and -fat mass compared to PLC 1 +/-mice [28] . Moreover, recent evidence has suggested a role for PLC 1 in the neurodegenerative disease, amyotrophic lateral sclerosis (ALS), as expression of PLC 1 in SOD1(G93A) mutant mice (animal model of ALS) was significantly up-regulated [29] .
Genetic deletion of PLC 1 in these mice significantly improved survival [29] , although the molecular mechanism underlying this process remains unresolved.
Although PLCδ1 is highly expressed in the nail matrix [1] the exact mechanism underlying PLCδ1 mutation leading to leukonychia is currently unclear. Here we have examined the effect of three HL-associated PLCδ1 mutations on the biophysical and enzymatic properties of rat PLCδ1. Additionally, we characterized a novel PLCδ1 mutation identified in a Pakistani family (S740RfsX19) [3] , generating the equivalent PLCδ1 mutant in rat PLCδ1 sequence by incorporating a stop codon 19 amino acids downstream of the S719R point mutation.
Within the C209R mutant protein, the relatively small cysteine residue is replaced by the larger, positively-charged arginine residue. Interestingly, attempts to crystallize the first EF hands of PLCδ1 were unsuccessful due to poorly ordered crystals [6, 30] , whereas the successful crystallization of the second EF hand suggests that this domain may contribute to the rather rigid core of PLCδ1 [6] . As presented in Fig. 6 , the Cys side-chain can be efficiently accommodated inside the hydrophobic interior of the protein. However, the same cannot apply to the much larger Arg side-chain. The presented model shows a contorted configuration to avoid clashes, using χ dihedral rotations. But this may not be a stable fold in
the vicinity. Our experimental observations ( Figure 2D) into an open groove created by neighbouring side-chains (Fig 6) that is large enough to accomodate the large Arg side-chain with appropriate χ dihedral rotations to avoid clashes.
The distal guanidinium group emerges into the solvent region, displacing solvent molecules found in the 1DJH structure, on which this model is based. Neighbouring active site domains are not significantly altered by this mutation. Contrastingly, although the S719R mutation did not affect enzymatic activity, truncation of the remaining 18 amino acids from the C-terminus exerted deleterious effects on PLC 1 stability and activity. This major dysfunction in the hydrolytic activity of the PLC 1 protein consequently leads to the leukonychia phenotype in the Pakistani family carrying the S740RfsX19 mutation [3] .
The most intriguing mutational effects were observed for the A553T (human: A574T) mutation occurring in the Y-domain (residues 489-606). Replacement of the small hydrophobic alanine side chain with the polar, hydrophilic threonine significantly increased catalytic activity. The Ala side-chain is completely enveloped inside the hydrophobic core of
the fold with optimal van der Waals distances to neighbouring residues (Fig 6) . A Thr sidechain is larger, and polar, causing steric hindrance in at least one location. The precise effect is not known without structure determination, but it can be envisaged that the strain is relieved by appropriate main/side-chain rearrangement in the vicinity to accommodate the residue change. It is plausible that these changes make for a different binding mode of the substrate, making it more available for the reaction, thus increasing enzymatic activity. It is also worth noting that although the A553T mutation is located in the Y domain, which has intact Ca 2+ binding site, the presence of Ca 2+ ion does not increase its thermal stability ( Figure   2D ). This suggests that A553T mutation, which is located close to the surface, has a significant impact on the fold stability in the presence of Ca 2+ ion, without affecting the enzymatic properties of this protein ( Figures 5A, B) .
Prior to studies implicating the involvement of mutations in the 3p21.3-p22 chromosomal region, only one other genetic linkage study investigated the autosomal dominant leukonychia that displayed no other related abnormalities [31] . This study concluded that mutations in the 12q13 region, encoding type II cytokeratins and hard keratins, were associated with HL [31] . Together with the more recent evidence implicating 
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MATERIALS AND METHODS
Plasmid construction
Rat PLCδ1 (GenBank accesion number M20637) in the pGEX-5X2 plasmid [20] ) and the aforementioned PLCδ1 mutants were amplified by PCR from the pGEX-5X2-PLCδ1 plasmid using Phusion polymerase
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(Finnzymes), and the appropriate primers to incorporate 5'-SalI and 3'-NotI sites. PLCδ1
WT and mutants were then cloned into the pHSIE vector. The primers used for the amplification were: 5'-ACCAGTCGACATGGACTCGGGTAGGGACTTCC-3' (forward) and 5'-GAGAGCGGCCGCTCAGTCCTGGATGGAGATCTTCAC-3' (reverse).
For the pETMM60-PLCδ1 S719 fsX19 deletion construct, PLCδ1 S719 fsX19 was amplified by PCR from the pGEX-5X2-PLCδ1 S719 plasmid using Phusion polymerase (Finnzymes) and the appropriate primers to incorporate 5'-SalI and 3'-NotI sites. PLCδ1
WT and mutants were then cloned into the pETMM60 vector. The primers used for the amplification were: 5'-ACCAGTCGACATGGACTCGGGTAGGGACTTCC-3' (forward) and 5'-GAGAGCGGCCGCTCACTTAGACAAGAGGTGGACATGG-3' (reverse).
pETMM60-PLCδ1
WT has been generated previously [18] .
Protein expression and purification
For 6xHis-SUMO2-intein-PLCδ1-fusion protein expression, Escherichia coli [BL21-CodonPlus(DE3)-RILP; Stratagene], transformed with the appropriate plasmid, was cultured at 37 °C until the A 600 nm reached 0.6. Protein expression was induced for 18 h at 16°C with
mM IPTG (isopropyl β-D-thiogalactopyranoside), (ForMedium). Bacterial cell pellets
were harvested by centrifugation at 6,000 g for 15 minutes, 4°C and then recombinant PLCδ1
proteins were purified as previously described [33] .
For NusA-6xHis-fusion protein expression, Escherichia coli [BL21-CodonPlus(DE3)-RILP; Stratagene], transformed with the appropriate pETMM60-PLCδ1 plasmid, was cultured at 37
°C until A600 reached 0.6, and protein expression was induced for 18 h at 16°C with 0.1 mM IPTG (ForMedium). Cells were harvested (6000 g for 15 min), resuspended in phosphate-
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buffered saline (PBS) containing protease inhibitor mixture (EDTA-free; Roche) and sonicated 4 x15 seconds on ice. Soluble NusA-6xHis fusion PLCδ1 protein was purified on Ni-NTA resin following standard procedures (Qiagen) and eluted with 275 mM imidazole.
Eluted proteins were dialysed overnight (10 000 MWCO; Pierce) at 4°C against 4 l of PBS.
SDS-PAGE and western blotting
Recombinant proteins were separated by SDS-PAGE as previously described [22] .
Separated proteins were transferred onto polyvinylidene difluoride membranes (Immobilon-P; Millipore) using a semi-dry transfer system (Trans-Blot SD; Bio-Rad) in buffer (48 mM from the absorption at 280 nm, assuming extinction coefficients calculated based on the amino acid composition [34] . CD spectra were deconvoluted for the secondary structure
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content using the CDsstr algorithm [35] as implemented in the Dichroweb server [36] with the SP175 reference data set [37] . 
Chemical denaturation and fluorescence measurements
The equilibrium unfolding of PLC 1 wild type and mutant forms was studied by monitoring changes in their intrinsic fluorescence as a function of guanidine hydrochloride concentration (GdmCl). After exciting the sample at 295 nm, fluorescence emission spectra from 300 to 450 nm were recorded using a QuantaMaster UV Vis spectrofluorometer (Photon Technology International, Inc. Birmingham, UK). Experiments were performed at 20˚C, and the slit widths were set at 1 nm for excitation and 3 nm for emission. Samples at a protein concentration of 1 M were incubated for 24 h before taking measurements to ensure that equilibrium was reached. To minimize bleaching effect, a scan rate of 2 nm/sec was used, with a band pass for both excitation and emission at 2 nm. Spectra were corrected for background contribution, and an intensity-weighted average emission wavelength was computed at each denaturant concentration. All measurements were repeated at least three times.
Gibbs free energy changes for the chemically-induced protein unfolding transition were determined using a three state equilibrium thermodynamic model:
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This article is protected by copyright. All rights reserved. The experimental data were plotted as intensity-weighted average emission wavelength change (using the native state as reference) versus the GdmCl concentration of the sample and analyzed by nonlinear least-squares fitting of a two-step unfolding function: Fluorescence data were analysed using Origin software (OriginLab, Northampton, MA).
Liposome preparation and binding assay
Unilamellar liposomes were prepared as previously described [17, 18] 
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Assay of PLC activity
PIP 2 hydrolytic activity of recombinant PLC proteins was assayed as described previously [19, 20] . 
